National Comprehensive Cancer Network

About NCCN

Zynx Health Partners with the National Comprehensive Cancer Network (NCCN) to Launch New Product

Chemotherapy templates developed by the NCCN to be included in Zynx OncologyCare™

Los Angeles, CA and Fort Washington, PA – May 30, 2008 – Zynx Health, the leader in evidence-based healthcare, today announced it will partner with the National Comprehensive Cancer Network (NCCN) to make NCCN chemotherapy templates available to users of the new Zynx OncologyCare™ product.

An alliance of 21 of the nation’s leading cancer centers, the NCCN is an authoritative source of information to help patients and health professionals make informed decisions about cancer care. The development of NCCN information is based on the independent evaluation of available scientific evidence integrated with the expert judgment of leading clinicians. The NCCN chemotherapy templates made available through Zynx OncologyCare will be based on the Clinical Practice Guidelines in Oncology™, a widely used source of information recognized as the standard of care for oncology in the United States.

“NCCN Chemotherapy Order Templates are derived from the NCCN Guidelines and are consistent with the NCCN Drugs and Biologics Compendium. United HealthCare has recognized the NCCN Compendium as its primary resource for making coverage determinations regarding the use of drugs and biologics in cancer care. The Centers for Medicare & Medicaid Services will be making its decision on the NCCN Compendium in a matter of weeks. As such, this new product offers providers a tool that can improve the safety of drug prescribing and administration and also can enhance practice efficiency,” said Bill McGivney, PhD, NCCN Chief Executive Officer.

Users of Zynx OncologyCare will also have access to AuthorSpace™, Zynx’s online tool for customizing, managing, and integrating clinical content. The catalog of NCCN templates will be pre-built and updated in AuthorSpace, allowing users a single online location in which to review, edit, and maintain their local templates. Once customized, templates can then be deployed into the clinician’s workflow either on paper, as HTML files, or by exporting them into a clinical information system. Many of Zynx Health’s more than 1,400 hospital clients already use AuthorSpace to customize and maintain evidence-based order sets and interdisciplinary plans of care.

“The partnership between Zynx Health and the NCCN will enable the point-of-care use of NCCN-based chemotherapy templates,” said David Rhew, MD, vice president of content development for Zynx Health. “This represents an important advancement in the area of oncology clinical decision support, and should lead to measurable improvements in the quality of cancer care.”

About Zynx Health
Zynx Health, a subsidiary of HEARST Corporation, is the leading provider of evidence-based clinical decision support. Its team of physicians, nurses, and allied health professionals rigorously reviews the latest peer-reviewed literature to develop clinical summaries and distill evidence-based best practices that help improve the quality of patient care. More than 1,400 hospitals nationwide trust evidence-based decision support from Zynx Health to address regulatory initiatives, optimize pay-for-performance reimbursement, and measurably improve the quality and safety of patient care. For more information about Zynx Health, visit www.zynx.com or call 888.333.ZYNX (9969).

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the healthcare delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other healthcare decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center
    Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital